We are live on ! Find out more
PCMI

Paradigm Capital Management Inc Portfolio holdings

AUM $2.61B
1-Year Est. Return 78.58%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+78.58%
3 Year Est. Return
+164.7%
5 Year Est. Return
+201.05%
10 Year Est. Return
+1,210.21%
AUM
$2.09B
AUM Growth
+$165M
Cap. Flow
+$1.79M
Cap. Flow %
0.09%
Top 10 Hldgs %
49.94%
Holding
137
New
6
Increased
24
Reduced
31
Closed
6

Top Buys

Rank Stock Value
1
ACLS icon
Axcelis
ACLS
+$31.9M
2
CRNC icon
Cerence
CRNC
+$18.9M
3
OFIX icon
Orthofix Medical
OFIX
+$14M
4
SIBN icon
SI-BONE Inc
SIBN
+$12.8M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$7.21M

Top Sells

Rank Stock Value
1
COHR icon
Coherent
COHR
+$37.9M
2
UCTT
Ultra Clean Holdings
UCTT
+$29M
3
MOD icon
Modine Manufacturing
MOD
+$25.5M
4
CTRN icon
Citi Trends
CTRN
+$5.44M
5
ENS icon
EnerSys
ENS
+$4.47M

Sector Composition

Rank Sector Weight
1 Technology 57.61%
2 Industrials 14.16%
3 Healthcare 13.38%
4 Consumer Discretionary 11.46%
5 Materials 2.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDRX
76
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.85M 0.14%
+370,600
New +$3.37M
GRMN
77
Garmin
GRMN
$60B
$2.84M 0.14%
19,075
– –
AZTA icon
78
Azenta
AZTA
$1.48B
$2.51M 0.12%
41,600
– –
RDNT icon
79
RadNet
RDNT
$5.69B
$2.48M 0.12%
50,900
– –
PRGS icon
80
Progress Software
PRGS
$1.76B
$2.41M 0.12%
45,300
– –
MXL icon
81
MaxLinear
MXL
$6.8B
$2.37M 0.11%
127,121
+3,821
+3% +$76.3K
RRX icon
82
Regal Rexnord
RRX
$11.9B
$2.2M 0.11%
12,200
– –
CCRN
83
DELISTED
Cross Country Healthcare
CCRN
$2.02M 0.1%
107,700
– –
CL icon
84
Colgate-Palmolive
CL
$74.4B
$1.78M 0.09%
19,800
– –
MASI
85
DELISTED
Masimo
MASI
$1.67M 0.08%
11,353
– –
LITE icon
86
Lumentum
LITE
$69.3B
$1.59M 0.08%
33,600
– –
LAB icon
87
Standard BioTools
LAB
$314M
$1.49M 0.07%
550,000
+500,000
+1,000% +$1.21M
GEN icon
88
Gen Digital
GEN
$17.5B
$1.48M 0.07%
66,000
– –
HROW icon
89
Harrow
HROW
$1.51B
$1.43M 0.07%
108,000
– –
GATX icon
90
GATX Corp
GATX
$6.27B
$1.43M 0.07%
10,650
– –
MYRG icon
91
MYR Group
MYRG
$5.25B
$1.41M 0.07%
8,000
– –
P
92
Everpure Inc
P
$29.9B
$1.4M 0.07%
27,000
– –
PPLI
93
People Inc
PPLI
$3.1B
$1.37M 0.07%
31,237
– –
OCUL icon
94
Ocular Therapeutix
OCUL
$2.02B
$1.27M 0.06%
140,000
-20,000
-13% -$142K
FORM icon
95
FormFactor
FORM
$9.17B
$1.27M 0.06%
27,900
– –
HI
96
DELISTED
Hillenbrand
HI
$1.17M 0.06%
23,300
– –
ETON icon
97
Eton Pharmaceutcials
ETON
$1.22B
$1.13M 0.05%
300,000
– –
FRME icon
98
First Merchants
FRME
$2.67B
$1.12M 0.05%
32,000
– –
CRS icon
99
Carpenter Technology
CRS
$28.4B
$1.11M 0.05%
15,600
– –
CI icon
100
Cigna
CI
$74.6B
$944K 0.05%
2,600
-100
-4% -$32.9K
2 3
4
5 6

Similar funds

MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return
CAAS
Capital Asset Advisory Services Williamston, Michigan $2.61B AUM 15.59% 1-Year Est. Return
RCMF
RK Capital Management (Florida) Weston, Florida $2.6B AUM 83.27% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
GAG
GM Advisory Group Melville, New York $2.6B AUM 18.86% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Paradigm Capital Management Inc's Q1 2024 Portfolio in Review

As of Q1 2024, Paradigm Capital Management Inc held 137 positions worth $2.09B, up 8.6% from $1.92B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Paradigm Capital Management Inc's Q1 2024 filing shows 6 new, 24 increased, 31 reduced and 6 closed positions. Its largest new stake was AngioDynamics: 1,079,100 shares worth $6.33M. The largest sale was Coherent, an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 58% of assets, down from 60% a quarter earlier, followed by Industrials and Healthcare.

  • Paradigm Capital Management Inc's largest Q1 2024 buy was AngioDynamics: 1,079,100 shares worth $6.33M.
  • Paradigm Capital Management Inc added most to Axcelis in Q1 2024, an estimated $31.9M increase.
  • Paradigm Capital Management Inc's biggest Q1 2024 reduction was Coherent, cutting an estimated $37.9M.
  • Paradigm Capital Management Inc fully exited Organon & Co in Q1 2024, selling an estimated $3.76M.
  • Paradigm Capital Management Inc's ten largest holdings make up 50% of its $2.09B portfolio in Q1 2024.
  • Paradigm Capital Management Inc opened 6 new positions and closed 6 in Q1 2024.
  • Paradigm Capital Management Inc's portfolio value rose 8.6% quarter-over-quarter to $2.09B.

Based on Paradigm Capital Management Inc's 13F filing for Q1 2024, filed 15 May 2024.